IL1-blocking therapy in colchicine-resistant familial Mediterranean fever.
Birgit Maria KöhlerHanns-Martin LorenzNorbert BlankPublished in: European journal of rheumatology (2018)
IL-1-blocking therapy was well tolerated over a median period of 2 years and reduced the frequency of FMF attacks in patients with colchicine-resistant FMF.